Arcturus Therapeutics Holdings (ARCT) EBT Margin (2018 - 2025)
Historic EBT Margin for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to 78.41%.
- Arcturus Therapeutics Holdings' EBT Margin fell 613200.0% to 78.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 68.35%, marking a year-over-year decrease of 294600.0%. This contributed to the annual value of 53.14% for FY2024, which is 364200.0% down from last year.
- According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' EBT Margin is 78.41%, which was down 613200.0% from 32.42% recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' EBT Margin ranged from a high of 74.02% in Q4 2022 and a low of 2711.14% during Q1 2021
- In the last 5 years, Arcturus Therapeutics Holdings' EBT Margin had a median value of 78.41% in 2025 and averaged 548.05%.
- In the last 5 years, Arcturus Therapeutics Holdings' EBT Margin plummeted by -23535500bps in 2021 and then surged by 26050700bps in 2022.
- Over the past 5 years, Arcturus Therapeutics Holdings' EBT Margin (Quarter) stood at 649.72% in 2021, then skyrocketed by 111bps to 74.02% in 2022, then plummeted by -150bps to 37.09% in 2023, then tumbled by -255bps to 131.81% in 2024, then skyrocketed by 41bps to 78.41% in 2025.
- Its EBT Margin stands at 78.41% for Q3 2025, versus 32.42% for Q2 2025 and 47.91% for Q1 2025.